Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
3,072 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01862562 | Trial to Evaluate Laparoscopic Versus Open Surgery in Elderly Colorectal Cancer Patients | unknown | Phase 3 | 200 | Shoichi Fujii, MD, PhDOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT00919737 |
| Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme |
| completed |
| Phase 1 / Phase 2 |
| 24 |
| NobelpharmaINDUSTRY |
| 1 |
| Oct 30, 2013 |
| clinicaltrials |
| NCT01969110 | Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy | unknown | Phase 4 | 60 | Chiba UniversityOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT00545246 | A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients | completed | Phase 1 | 12 | SanofiINDUSTRY | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01095302 | Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors | completed | Phase 1 | 11 | SanofiINDUSTRY | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00823355 | Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies | completed | Phase 1 | 24 | Mundipharma K.K.INDUSTRY | 1 | Sep 23, 2013 | clinicaltrials |
| NCT00079287 | Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | — | Japan Multinational Trial OrganizationOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00088816 | S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer | unknown | Phase 2 | 50 | Kyoto UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00134095 | S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | unknown | Phase 2 | 70 | Fukushima Medical University HospitalOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01020786 | A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients | completed | Phase 4 | 109 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
| NCT00766480 | Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus | unknown | N/A | 160 | University of ToyamaOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00753688 | Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy(PALETTE) | completed | Phase 3 | 369 | GlaxoSmithKlineINDUSTRY | 13 | Aug 22, 2013 | clinicaltrials |
| NCT00633724 | Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 9 | Fukushima Medical UniversityOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00874588 | Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 6 | Fukushima Medical UniversityOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00965523 | Study of E7389 for Advanced or Metastatic Breast Cancer | completed | Phase 2 | 81 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00245089 | Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma | unknown | Phase 2 | 41 | Japan Rhabdomyosarcoma Study GroupOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00245141 | Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | unknown | Phase 2 | 32 | Japan Rhabdomyosarcoma Study GroupOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00616031 | Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer | unknown | Phase 2 | 150 | Kyoto UniversityOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00974389 | S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | unknown | Phase 2 | 40 | Osaka Medical CollegeOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01861678 | Randomized Controlled Trial to Evaluate High Tie Versus Low Tie of the Inferior Mesenteric Artery in Anterior Resection | unknown | Phase 3 | 331 | Shoichi Fujii, MD, PhDOTHER | 1 | Aug 6, 2013 | clinicaltrials |
| NCT00805142 | Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants | completed | Phase 2 | 78 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | Jul 29, 2013 | clinicaltrials |
| NCT00107393 | Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 75 | Tohoku UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00516750 | Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin | terminated | Phase 2 | 100 | Kyoto UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00588913 | Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases | completed | Phase 1 / Phase 2 | 20 | Tokyo Women's Medical UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01118845 | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma | completed | Phase 2 | 63 | SymBio PharmaceuticalsINDUSTRY | 2 | Jul 4, 2013 | clinicaltrials |
| NCT01371227 | A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma | completed | Phase 1 | 3 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | Jul 4, 2013 | clinicaltrials |
| NCT01351688 | An Open Label Prostate Cancer Study in Japanese Patients | completed | Phase 1 | 13 | AstraZenecaINDUSTRY | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01887561 | Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial | unknown | Phase 2 | 100 | Kanto CML Study GroupOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00182611 | S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer | completed | Phase 3 | 100 | Kyoto UniversityOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00486954 | Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer | completed | Phase 3 | 273 | GlaxoSmithKlineINDUSTRY | 4 | Jun 20, 2013 | clinicaltrials |
| NCT00644787 | A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain | completed | Phase 2 / Phase 3 | 156 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | Jun 13, 2013 | clinicaltrials |
| NCT00663741 | Sorafenib Gastric Cancer Asian Phase I Study | completed | Phase 1 | 13 | BayerINDUSTRY | 1 | Jun 11, 2013 | clinicaltrials |
| NCT00641667 | An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain | completed | Phase 3 | 66 | Janssen Pharmaceutical K.K.INDUSTRY | 1 | Jun 7, 2013 | clinicaltrials |
| NCT01413906 | Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors | completed | Phase 1 | 12 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00104793 | Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00132054 | Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 30 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | withdrawn | Phase 3 | 0 | Kyoto UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00662025 | Study Of Sunitinib With Capecitabine In Breast Cancer | completed | Phase 2 | 63 | PfizerINDUSTRY | 1 | May 27, 2013 | clinicaltrials |
| NCT01213381 | Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | SanofiINDUSTRY | 1 | May 24, 2013 | clinicaltrials |
| NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | unknown | Phase 2 | 90 | Aichi Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00336947 | S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer | unknown | Phase 3 | 500 | Yokohama City UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01003808 | Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer | completed | Phase 1 | 25 | ImmunoFrontier, Inc.INDUSTRY | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00054067 | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix | terminated | Phase 3 | — | Gynecologic Oncology GroupNETWORK | 2 | Apr 11, 2013 | clinicaltrials |
| NCT00603538 | Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer | completed | Phase 1 | 19 | PfizerINDUSTRY | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT00243113 | Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx | completed | Phase 2 | 50 | Aichi Cancer CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01463059 | Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy | completed | Phase 2 | 119 | UCB Japan Co. Ltd.INDUSTRY | 3 | Mar 25, 2013 | clinicaltrials |
| NCT00494091 | Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 82 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials